Search hospitals > Wisconsin > Minocqua

Marshfield Clinic-Minocqua Center

Claim this profile
Minocqua, Wisconsin 54548
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
307 reported clinical trials
24 medical researchers
Photo of Marshfield Clinic-Minocqua Center in MinocquaPhoto of Marshfield Clinic-Minocqua Center in MinocquaPhoto of Marshfield Clinic-Minocqua Center in Minocqua

Summary

Marshfield Clinic-Minocqua Center is a medical facility located in Minocqua, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Marshfield Clinic-Minocqua Center is involved with conducting 307 clinical trials across 459 conditions. There are 24 research doctors associated with this hospital, such as Seth O. Fagbemi, Adedayo A. Onitilo, Chady A. Leon, MD, and Demet Gokalp Yasar.

Area of expertise

1Cancer
Global Leader
Marshfield Clinic-Minocqua Center has run 125 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Marshfield Clinic-Minocqua Center has run 42 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 negative
Stage IV

Top PIs

Clinical Trials running at Marshfield Clinic-Minocqua Center

Breast Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Cancer
Lung Cancer
Bladder Carcinoma
Diffuse Large B-Cell Lymphoma
Renal Cell Carcinoma
Squamous Cell Carcinoma
Lymphoma
Image of trial facility.

Hormone Therapy with or without Radiation

for Breast Cancer

This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Marshfield Clinic-Minocqua Center?
Marshfield Clinic-Minocqua Center is a medical facility located in Minocqua, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Marshfield Clinic-Minocqua Center is involved with conducting 307 clinical trials across 459 conditions. There are 24 research doctors associated with this hospital, such as Seth O. Fagbemi, Adedayo A. Onitilo, Chady A. Leon, MD, and Demet Gokalp Yasar.